In Memoriam: W. King Engel, MD (1930-2025)
February 13, 2026
It is with deep saddness that we share the passing of Dr. William King Engel. He was an extraordinary neurologist and mentor whose compassion and
Alumnus Razzaque Ahmed, MD honors HSDM with $1 million gift to support oral medicine research and faculty mentorship
January 29, 2026
Dr. Razzaque Ahmed with Dean William G. Giannobile and Dr. Magda Feres, Head Dept of Oral Medicine, at the inauguration of the Ahmed Research Fund
A. Razzaque Ahmed, MD Endowed Professorship in Dermatology at Tufts Medical Center
May 24, 2025
Boston, MA – May 23, 2024 We are proud to celebrate A. Razzaque Ahmed, MD’s contributions to dermatology, immunology, and the Tufts community. The Tufts
Groundbreaking Study Demonstrates 20-Year Remission in Pemphigus Vulgaris Patients Using IVIg Therapy
January 29, 2024
Research published in the prestigious Proceedings of the National Academy of Sciences of the United States of America (PNAS) offers hope for long-term remission in
Restoring immune tolerance in pemphigus vulgaris
January 24, 2024
Intravenous immunoglobulin (IVIg), a preparation of polyclonal serum IgG pooled from numerous blood donors, has been used for nearly three decades and is proving to
Pemphigoid of the Pulmonary System (POPS): A Review of a Less Recognized Feature
December 21, 2022
Pemphigoid (Pg) diseases are a group of potentially fatal autoimmune mucocutaneous diseases. They have different clinical phenotypes, involving only the skin or multiple mucous membranes.
Molecular Basis for Global Incidence of Pemphigoid Diseases and Differences in Phenotypes
December 21, 2022
Pemphigoid (Pg) diseases are a group of potentially fatal autoimmune mucocutaneous diseases. They have different clinical phenotypes, involving only the skin or multiple mucous membranes.
Use of Rituximab in the Treatment of Mucous Membrane Pemphigoid: An Analytic Review
December 21, 2022
Pemphigoid (Pg) diseases are a group of potentially fatal autoimmune mucocutaneous diseases. They have different clinical phenotypes, involving only the skin or multiple mucous membranes.
Molecular Basis for Global Incidence of Pemphigoid Diseases and Differences in Phenotypes
February 2, 2022
Pemphigoid (Pg) diseases are a group of potentially fatal autoimmune mucocutaneous diseases. They have different clinical phenotypes, involving only the skin or multiple mucous membranes.
IgM Deficiency in Autoimmune Blistering Mucocutaneous Diseases Following Various Treatments: Long Term Follow-Up and Relevant Observations
October 22, 2021
Link to original article: https://www.frontiersin.org/articles/10.3389/fimmu.2021.727520/full A. Razzaque Ahmed1,2* and Merve Aksoy1 1Department of Dermatology, The Center for Blistering Diseases, Tufts University School of Medicine, Boston, MA, United
Pemphigus Vulgaris (PV) Treatment Strategies
July 23, 2020
Pemphigus vulgaris (PV) is an autoimmune mucocutaneous blistering disease (AMBD). AMBDs are a group of frequently fatal diseases…
Welcome to Dysimmune Diseases Foundation!
August 5, 2019
Learn about how we got started and what we do!